FDA Drug Safety Communication: FDA warns about prescribing and dispensing errors resulting from brand name confusion with antidepressant Brintellix (vortioxetine) and antiplatelet Brilinta (ticagrelor).
Public Meeting on Improving Patient Safety by Enhancing the Container Labeling for Parenteral Infusion Drug Products.
US Food and Drug Administration, Center for Drug Evaluation and Research. January 11, 2007.
ReliOn insulin syringes for use with U-100 insulin (Tyco Healthcare-Covidien).
MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; November 6, 2008.
Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002.
Wysowski DK, Swartz L. Arch Intern Med. 2005;165:1363-1369.
PRESS RELEASE/ANNOUNCEMENTView all related resources...
Safety warnings regarding use of fentanyl transdermal (skin) patches.
FDA Public Health Advisory. Silver Spring, MD: US Food and Drug Administration; December 21, 2007.